The studies were conducted by the HIV Vaccine Trials Network . Inovio's HIV DNA vaccine together with the CELLECTRA device significantly increased the number of responders producing robust and durable CD4 and CD8 T-cell responses in humans.
http://www.biospace.com/news_story.aspx?StoryID=302308&full=1
http://www.biospace.com/news_story.aspx?StoryID=302308&full=1
No comments:
Post a Comment